Changes

no edit summary
Line 1: Line 1:  +
{{DISPLAYTITLE:In Situ Mantle Cell Neoplasia}}
 +
 +
 +
<blockquote class='blockedit'>{{Box-round|title=PREVIOUS EDITION|This page from the 4th edition of Haematolymphoid Tumours is being updated. See 5th edition [[HAEM5:Table_of_Contents|Table of Contents]].
 +
}}</blockquote>
 
==Primary Author(s)*==
 
==Primary Author(s)*==
   Line 536: Line 541:  
==Links==
 
==Links==
   −
[[Mantle Cell Lymphoma]]
+
[[HAEM5:Mantle cell lymphoma]]
   −
[[Leukemic Non-Nodal Mantle Cell Lymphoma]]
+
[[HAEM5:Leukaemic non-nodal mantle cell lymphoma]]
   −
[[Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma]]
+
[[HAEM5:Chronic lymphocytic leukaemia/small lymphocytic lymphoma]]
    
National Comprehensive Cancer Network (NCCN) Guidelines. B-cell Lymphomas. Version 5.2022 — July 12, 2022. Accessed July 25, 2022[https://www.nccn.org/professionals/physician_gls/pdf/b-cell.pdf]
 
National Comprehensive Cancer Network (NCCN) Guidelines. B-cell Lymphomas. Version 5.2022 — July 12, 2022. Accessed July 25, 2022[https://www.nccn.org/professionals/physician_gls/pdf/b-cell.pdf]
Line 550: Line 555:  
==Notes==
 
==Notes==
 
<nowiki>*</nowiki>Primary authors will typically be those that initially create and complete the content of a page.  If a subsequent user modifies the content and feels the effort put forth is of high enough significance to warrant listing in the authorship section, please contact the CCGA coordinators (contact information provided on the homepage).  Additional global feedback or concerns are also welcome.
 
<nowiki>*</nowiki>Primary authors will typically be those that initially create and complete the content of a page.  If a subsequent user modifies the content and feels the effort put forth is of high enough significance to warrant listing in the authorship section, please contact the CCGA coordinators (contact information provided on the homepage).  Additional global feedback or concerns are also welcome.
 +
[[Category:HAEM4]] [[Category:DISEASE]]